buflomedil and Recrudescence

buflomedil has been researched along with Recrudescence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Col-Debeys, C; Crasborn, L; Lavenne-Pardonge, E; Moriau, M; von Frenckell, R1
Barlattani, A; De Martiis, A; De Martiis, M; Parenzi, A1

Trials

2 trial(s) available for buflomedil and Recrudescence

ArticleYear
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants.
    Thrombosis research, 1995, Jun-15, Volume: 78, Issue:6

    Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Blood Viscosity; Dipyridamole; Drug Therapy, Combination; Female; Hemorheology; Heparin; Humans; Male; Middle Aged; Pentoxifylline; Piracetam; Platelet Aggregation Inhibitors; Pyrrolidines; Recurrence; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Venous Thrombosis; Vitamin K

1995
[Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    La Clinica terapeutica, 1986, Mar-15, Volume: 116, Issue:5

    Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Ischemic Attack, Transient; Pyrrolidines; Random Allocation; Recurrence; Vasodilator Agents

1986